Frailty and Body Composition in the Elderly Cancer Patients Treated With Chemotherapy

Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients

NCT00139204 ·Status: COMPLETED ·Phase: NA

Prospective Study of Detection of Sarcopenia in Clinical Practice for Patient With Ovarian or Endometrial Cancer

NCT05833321 ·Status: RECRUITING ·Phase: NA

Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET

NCT00904410 ·Status: COMPLETED ·Phase: PHASE4

PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy

NCT04272658 ·Status: RECRUITING

CT Assessment of BMI in Endometrial Cancer Patients

NCT03962140 ·Status: COMPLETED

Predicting Lung Cancer-Associated Cachexia With PET Imaging

NCT05912465 ·Status: UNKNOWN ·Phase: NA

Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET

NCT00180154 ·Status: COMPLETED

Repeatability of Positron Emission Tomography (TEP) With fluorométhyl-(18F)-diméthyl-2-hydroxyéthyl-ammonium

NCT03105869 ·Status: COMPLETED ·Phase: NA

Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy

NCT01482182 ·Status: COMPLETED

Study of Factors Associated With Significant MYoCArdian Uptake on 68Ga-DOTATOC PET Scans for Oncology

NCT05478733 ·Status: COMPLETED

PET Response During Chemoradiation of Lung Cancer

NCT02315053 ·Status: COMPLETED ·Phase: NA

Parametric Imaging in Positron Emission Tomography for Patient With Lung Cancer

NCT02821936 ·Status: COMPLETED ·Phase: NA

Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT

NCT01261585 ·Status: COMPLETED

Study Evaluating the Utility of 18F-FDG PET in Assessing Early Response to Neoadjuvant Chemotherapy in Patients With Mammary Gland Cancer

NCT02386709 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Elevated LDH Serum Levels and FDG-PET in Metastatic Melanoma Patients

NCT02949154 ·Status: COMPLETED

Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer Patients

NCT03648151 ·Status: COMPLETED

Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy

NCT02317393 ·Status: COMPLETED ·Phase: PHASE2

Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung Cancer

NCT02490696 ·Status: COMPLETED ·Phase: PHASE2

Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET

NCT00180245 ·Status: COMPLETED

Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer

NCT03442504 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic Adenocarcinoma

NCT02876991 ·Status: UNKNOWN ·Phase: NA

Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy

NCT01269970 ·Status: COMPLETED

18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study

NCT02938546 ·Status: UNKNOWN ·Phase: PHASE3

Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer

NCT01336231 ·Status: TERMINATED

Prognostic Value of 18FDG PET/CT Textural Indices in HNSCC

NCT03378193 ·Status: COMPLETED